Passing of Genmab A/S' Annual General Meeting

Company Announcement At Genmab A/S' Annual General Meeting held today March 19, 2026, the Annual Report for 2025 was approved Discharge was given to the Board of Directors and the Executive Management and the year's profit was carried forward The 2025 Compensation Report was approved Six members of the Board of Directors were re-elected Deloitte was re-elected as the auditor of the Company The proposal from the Board of Directors to reduce the Company's share capital with nominally DKK 1,900,000 by cancellation of the Company's holding of shares was adopted COPENHAGEN, Denmark; March 19, 2026 –  Genmab A/S  (Nasdaq: GMAB) held its Annual General Meeting, today at the Copenhagen Marriott Hotel, Copenhagen, Denmark. At the meeting, Deirdre P.